Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart M Flechner

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|March 26, 2016
Emergency Department Visits after Kidney TransplantationJesse D Schold, Nissreen Elfadawy, Laura D Buccini, et al.
Transplantation|December 23, 2003
The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipientsStuart M Flechner, Lingmei Zhou, Ithaar Derweesh, et al.
Transplantation|January 22, 2009
A systematic approach to minimizing wound problems for de novo sirolimus-treated kidney transplant recipientsHo Yee Tiong, Stuart M Flechner, Lingme Zhou, et al.
Transplantation|November 10, 2005
Laparoscopic donor nephrectomy gene expression profiling reveals upregulation of stress and ischemia associated genes compared to control kidneysSunil M Kurian, Stuart M Flechner, Jihad Kaouk, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 12, 2018
Residential Area Life Expectancy: Association With Outcomes and Processes of Care for Patients With ESRD in the United StatesJesse D Schold, Stuart M Flechner, Emilio D Poggio, et al.
Medical Care|August 25, 2010
Hidden selection bias deriving from donor organ characteristics does not affect performance evaluations of kidney transplant centersJesse D Schold, Titte R Srinivas, Emilio D Poggio, et al.
Transplantation|September 24, 2013
CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantationNissreen Elfadawy, Stuart M Flechner, Xiaobo Liu, et al.
Transplantation|November 20, 2002
Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporineStuart M Flechner, David Goldfarb, Charles Modlin, et al.
Transplantation|November 3, 2010
The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantationStuart M Flechner, Richard Fatica, Medhat Askar, et al.
Transplantation|April 12, 2011
Combined liver-kidney transplants: allosensitization and recipient outcomesMedhat Askar, Jesse D Schold, Bijan Eghtesad, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Clinical Journal of the American Society of Nephrology : CJASN|March 26, 2016
Emergency Department Visits after Kidney TransplantationJesse D Schold, Nissreen Elfadawy, Laura D Buccini, et al.
Transplantation|December 23, 2003
The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipientsStuart M Flechner, Lingmei Zhou, Ithaar Derweesh, et al.
Transplantation|January 22, 2009
A systematic approach to minimizing wound problems for de novo sirolimus-treated kidney transplant recipientsHo Yee Tiong, Stuart M Flechner, Lingme Zhou, et al.
Transplantation|November 10, 2005
Laparoscopic donor nephrectomy gene expression profiling reveals upregulation of stress and ischemia associated genes compared to control kidneysSunil M Kurian, Stuart M Flechner, Jihad Kaouk, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 12, 2018
Residential Area Life Expectancy: Association With Outcomes and Processes of Care for Patients With ESRD in the United StatesJesse D Schold, Stuart M Flechner, Emilio D Poggio, et al.
Medical Care|August 25, 2010
Hidden selection bias deriving from donor organ characteristics does not affect performance evaluations of kidney transplant centersJesse D Schold, Titte R Srinivas, Emilio D Poggio, et al.
Transplantation|September 24, 2013
CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantationNissreen Elfadawy, Stuart M Flechner, Xiaobo Liu, et al.
Transplantation|November 20, 2002
Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporineStuart M Flechner, David Goldfarb, Charles Modlin, et al.
Transplantation|November 3, 2010
The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantationStuart M Flechner, Richard Fatica, Medhat Askar, et al.
Transplantation|April 12, 2011
Combined liver-kidney transplants: allosensitization and recipient outcomesMedhat Askar, Jesse D Schold, Bijan Eghtesad, et al.
Pageof 8